Quick Answer
Jasper Therapeutics, Inc. reported Total Assets of $35.78 million for fiscal year 2025.
Jasper Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $35.78M | -55.2% |
| 2024 | $79.90M | -15.8% |
| 2023 | $94.89M | +96.2% |
| 2022 | $48.36M | -48.4% |
| 2021 | $93.65M | +301.0% |
| 2020 | $23.36M | -77.0% |
| 2019 | $101.69M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $57.47M | -42.2% | +23.7% |
| June 30, 2025 | $46.47M | -59.2% | -19.3% |
| March 31, 2025 | $57.60M | -54.3% | -27.9% |
| December 31, 2024 | $79.90M | -15.8% | -19.6% |
| September 30, 2024 | $99.41M | -10.0% | -12.7% |
| June 30, 2024 | $113.93M | -8.2% | -9.6% |
| March 31, 2024 | $125.96M | -9.2% | +32.7% |
| December 31, 2023 | $94.89M | +96.2% | -14.1% |
- Jasper Therapeutics, Inc. showed a decrease of -55.2% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Jasper Therapeutics, Inc.’s total assets has declined by 64.8% (from $101.69 million to $35.78 million).
- The most recent figure is from Jasper Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: